Insulin resistance and medial prefrontal gyrus metabolism in women receiving hormone therapy.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Psychiatry Research

• Publication date

  2014-07-30

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1016/j.pscychresns.2014.04.004PMID 24819305
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Wechsler Abbreviated Scale of Intelligence

  2014cited by this paper
• Prospective Randomized Trial to Assess Effects of Continuing Hormone Therapy on Cerebral Function in Postmenopausal Women at Risk for Dementia

  2014cited by this paper
• 2013 Alzheimer's disease facts and figures

  2013cited by this paper
• Insulin Resistance, Brain Atrophy, and Cognitive Performance in Late Middle–Aged Adults

  2013cited by this paper
• Fasting plasma insulin and the default mode network in women at risk for Alzheimer's disease.

  2013cited by this paper
• The association of elective hormone therapy with changes in lipids among glucose intolerant postmenopausal women in the diabetes prevention program.

  2013influential reference
• Interactions between estradiol, BDNF and dendritic spines in promoting memory.

  2013cited by this paper
• Preclinical sporadic Alzheimer's disease: target for personalized diagnosis and preventive intervention.

  2013cited by this paper
• Cognitive function in normal aging and in older adults with mild cognitive impairment.

  2013cited by this paper
• Lost in Transition: Aging-Related Changes in Executive Control by the Medial Prefrontal Cortex

  2012cited by this paper
• Intranasal insulin therapy for Alzheimer disease and amnestic mild cognitive impairment: a pilot clinical trial.

  2012cited by this paper
• Low cerebral blood flow is associated with lower memory function in metabolic syndrome

  2012cited by this paper
• Type 2 diabetes affects hippocampus volume differentially in men and women

  2012influential reference
• Aging redistributes medial prefrontal neuronal excitability and impedes extinction of trace fear conditioning.

  2012cited by this paper
• The effects of long-term treatment with estradiol and medroxyprogesterone acetate on tyrosine hydroxylase fibers and neuron number in the medial prefrontal cortex of aged female rats.

  2012cited by this paper
• Perimenopausal use of hormone therapy is associated with enhanced memory and hippocampal function later in life.

  2011cited by this paper
• Differences in verbal memory performance in postmenopausal women receiving hormone therapy: 17β-estradiol versus conjugated equine estrogens.

  2011cited by this paper
• Insulin resistance and hippocampal volume in women at risk for Alzheimer's disease.

  2011cited by this paper
• Brain Insulin Signaling and Alzheimer's Disease: Current Evidence and Future Directions

  2011cited by this paper
• Differences in regional brain metabolism associated with specific formulations of hormone therapy in postmenopausal women at risk for AD.

  2011influential reference
• Structural organization of the prefrontal white matter pathways in the adult and aging brain measured by diffusion tensor imaging

  2011cited by this paper
• Early initiation of hormone therapy in menopausal women is associated with increased hippocampal and posterior cingulate cholinergic activity.

  2011cited by this paper
• Intranasal Insulin Therapy for Alzheimer Disease and Amnestic Mild Cognitive Impairment A Pilot Clinical Trial

  2011cited by this paper
• Effects of endogenous and exogenous estrogen exposures in midlife and late-life women on episodic memory and executive functions.

  2011cited by this paper
• Insulin resistance and Alzheimer-like reductions in regional cerebral glucose metabolism for cognitively normal adults with prediabetes or early type 2 diabetes.

  2011influential reference
• Cognitive impairment in nondiabetic middle-aged and older adults is associated with insulin resistance

  2010cited by this paper
• Meta-analysis of Alzheimer's disease risk with obesity, diabetes, and related disorders.

  2010influential reference
• Early menopausal hormone use influences brain regions used for visual working memory

  2010cited by this paper
• Neuroprotection of sex steroids.

  2010influential reference
• Effect of sex and estrogen therapy on the aging brain: a voxel-based morphometry study

  2010cited by this paper
• Age-Associated Increase in Abdominal Obesity and Insulin Resistance, and Usefulness of AHA/NHLBI Definition of Metabolic Syndrome for Predicting Cardiovascular Disease in Japanese Elderly with Type 2 Diabetes Mellitus

  2009cited by this paper
• Postmenopausal hormone therapy and regional brain volumes

  2009cited by this paper
• Faculty Opinions recommendation of Postmenopausal hormone therapy and regional brain volumes: the WHIMS-MRI Study.

  2009cited by this paper
• Brain volumes, cognitive impairment, and conjugated equine estrogens.

  2009cited by this paper
• The role of metabolic disorders in Alzheimer disease and vascular dementia: two roads converged.

  2009influential reference
• Thalamo-Basal Ganglia Connectivity in Postmenopausal Women Receiving Estrogen Therapy

  2009cited by this paper
• The relationship between type 2 diabetes and dementia.

  2008cited by this paper
• [18F]2-fluoro-2-deoxy-D-glucose positron emission tomography demonstration of estrogen negative and positive feedback on luteinizing hormone secretion in women.

  2008cited by this paper
• Neurotrophic and neuroprotective actions of estrogen: basic mechanisms and clinical implications.

  2007cited by this paper
• Altered frontocortical, cerebellar, and basal ganglia activity in adjuvant-treated breast cancer survivors 5–10 years after chemotherapy

  2007cited by this paper
• Estrogen therapy selectively enhances prefrontal cognitive processes: a randomized, double-blind, placebo-controlled study with functional magnetic resonance imaging in perimenopausal and recently postmenopausal women

  2006cited by this paper
• Insulin Resistance Syndrome and Alzheimer Disease: Pathophysiologic Mechanisms and Therapeutic Implications

  2006cited by this paper
• Mechanisms of neuroprotection by estrogen

  2006cited by this paper
• TEST REVIEW: Dean C. Delis, Edith Kaplan & Joel H. Kramer, Delis Kaplan Executive Function System (D-KEFS), The Psychological Corporation, San Antonio, TX, 2001. $415.00 (complete kit)

  2006cited by this paper
• Increased action potential firing rates of layer 2/3 pyramidal cells in the prefrontal cortex are significantly related to cognitive performance in aged monkeys.

  2005cited by this paper
• Age-related alterations in white matter microstructure measured by diffusion tensor imaging.

  2005cited by this paper
• Use of waist circumference to predict insulin resistance: retrospective study

  2005cited by this paper
• Sarcopenia of aging and its metabolic impact.

  2005cited by this paper
• Insulin Resistance and Postmenopausal Hormone Replacement Therapy

  2004cited by this paper
• Estrogen use and brain metabolic change in postmenopausal women.

  2004cited by this paper
• Brain Regions Activated during an Auditory Discrimination Task in Insomniac Postmenopausal Patients before and after Hormone Replacement Therapy: Low-Resolution Brain Electromagnetic Tomography Applied to Event-Related Potentials

  2004cited by this paper
• Increase in prefrontal cortex serotonin 2A receptors following estrogen treatment in postmenopausal women.

  2003cited by this paper
• Insulin dose-response effects on memory and plasma amyloid precursor protein in Alzheimer's disease: interactions with apolipoprotein E genotype.

  2003cited by this paper
• Hormone Replacement Therapy Decreases Insulin Resistance and Lipid Metabolism in Japanese Postmenopausal Women with Impaired and Normal Glucose Tolerance

  2003cited by this paper
• Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial.

  2003cited by this paper
• Insulin resistance as the core defect in type 2 diabetes mellitus.

  2002cited by this paper
• Estrogen use and brain metabolic change in older adults. A preliminary report.

  2001cited by this paper
• Insulin Effects on Glucose Metabolism, Memory, and Plasma Amyloid Precursor Protein in Alzheimer's Disease Differ According to Apolipoprotein‐E Genotype

  2000cited by this paper
• Soy isoflavones: are they useful in menopause?

  2000cited by this paper
• Effect of estrogen on brain activation patterns in postmenopausal women during working memory tasks.

  2000cited by this paper
• Biological properties of genistein. A review of in vitro and in vivo data.

  2000cited by this paper
• Comparison of insulin sensitivity tests across a range of glucose tolerance from normal to diabetes

  1999cited by this paper
• Prefrontal gray and white matter volumes in healthy aging and Alzheimer disease.

  1999cited by this paper
• Effect of Estrogen on Brain Activation Patterns in Postmenopausal Women During Working Memory Tasks

  1999cited by this paper
• How to measure insulin sensitivity

  1998cited by this paper
• Menopause, central body fatness, and insulin resistance: effects of hormone‐replacement therapy

  1998cited by this paper
• Regional cerebral activity in normal and pathological perception of visceral pain.

  1997cited by this paper
• Utilization of 3-D elastic transformation in the registration of chest X-ray CT and whole body PET

  1996cited by this paper
• A Follow‐Up Study of Age‐Associated Memory Impairment: Neuropsychological Predictors of Dementia

  1995cited by this paper
• Predictors of cognitive change in middle-aged and older adults with memory loss.

  1995cited by this paper
• Confirmation of association between the e4 allele of apolipoprotein E and Alzheimer's disease.

  1994cited by this paper
• Statistical parametric maps in functional imaging: A general linear approach

  1994cited by this paper
• Effects of hyperglycemia on memory and hormone levels in dementia of the Alzheimer type: a longitudinal study.

  1993cited by this paper
• Abnormal brain glucose metabolism in Alzheimer's disease, as measured by position emission tomography.

  1991cited by this paper
• Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man

  1985influential reference
• “Mini-mental state”: A practical method for grading the cognitive state of patients for the clinician

  1975cited by this paper
• Evaluating storage, retention, and retrieval in disordered memory and learning

  1974cited by this paper
• Disorders of learning and memory after temporal lobe lesions in man.

  1972influential reference
• A RATING SCALE FOR DEPRESSION

  1960influential reference
• Le test de copie d'une figure complexe; contribution à l'étude de la perception et de la mémoire.

  1944cited by this paper
• For Personal Use. Only Reproduce with Permission the Lancet Publishing Group. Insulin and the Brain Insulin and Neurodegenerative Disease Insulin and Neurodegenerative Disease: Shared and Specific Mechanisms

  year unknowncited by this paper

• Relationships Between Brain Glucose Metabolism Patterns and Impaired Glycemic Status: A Systematic Review of FDG‐PET Studies With a Focus on Alzheimer's Disease

  2025influential citation
• Metabolic Status Modulates Global and Local Brain Age Estimates in Overweight and Obese Adults.

  2024cites this paper
• Sexual and Metabolic Differences in Hippocampal Evolution: Alzheimer’s Disease Implications

  2024cites this paper
• Long−term health outcome and quality of life in children with multisystem inflammatory syndrome: findings from multidisciplinary follow−up at an Italian tertiary−care paediatric hospital

  2024cites this paper
• Obesity and risk of depressive disorder in children and adolescents: A meta-analysis of observational studies.

  2024cites this paper
• The Historical Progression of Positron Emission Tomography Research in Neuroendocrinology.

  2023cites this paper
• The physio-affective phenome of major depression is strongly associated with biomarkers of astroglial and neuronal projection toxicity which in turn are associated with peripheral inflammation, insulin resistance and lowered calcium

  2022cites this paper
• Exercise Paucity and Sedentary Routines: Genocide Conduits to Health Impairments in Adult Academics at Great Zimbabwe University

  2022cites this paper
• Increased insulin resistance due to long COVID is associated with depressive symptoms and partly predicted by the inflammatory response during acute infection

  2022cites this paper
• Insulin resistance and accelerated cognitive aging.

  2022cites this paper
• Obesity and depression: A molecular and epidemiological view of two comorbid disorders

  2022cites this paper
• Interactions between estradiol, diabetes, and brain aging and the risk for cognitive impairment

  2021cites this paper
• Depression and Obesity: Analysis of Common Biomarkers

  2020cites this paper
• The Neurological and Immunological Transitions of the Perimenopause: Implications for Postmenopausal Neurodegenerative Disease

  2019cites this paper
• Depression and obesity: evidence of shared biological mechanisms

  2018cites this paper
• Neuroprotection in Perimenopausal Women

  2018cites this paper
• Neurobiological and Systemic Effects of Chronic Stress

  2017cites this paper
• 5.19 – Reproductive Aging of Neuroendocrine Systems

  2017cites this paper
• Insulin Resistance as a Link between Amyloid-Beta and Tau Pathologies in Alzheimer’s Disease

  2017cites this paper
• Insulin resistance—a missing link no more

  2016cites this paper
• Cholesterol Diet-Associated Changes in the Hippocampus - A Prelude to Alzheimer's Disease?

  2016cites this paper
• Postmenopausal hormone therapy, type 2 diabetes mellitus, and brain volumes

  2015cites this paper
• Perimenopause as a neurological transition state

  2015cites this paper
• Cognitive Effects of Hormone Therapy Continuation or Discontinuation in a Sample of Women at Risk for Alzheimer Disease.

  2015cites this paper
• GONADECTOMIA E DHEA: EFEITOS METABÓLICOS EM RATAS ADULTAS ALIMENTADAS COM DIETA HIPERLIPÍDICA

  2014cites this paper